共 11 条
[1]
Immunohistochemical studies on the main entrance-route of CA19-9 into the peripheal venous blood of gastric cancer patients. Tabuchi Y,Degucai H,Lmamishi K,et al. Cancer . 1990
[3]
Sensitivity specificity CA24-2 in gastrointestinal cancer: a comparison with CEA, Ca50 and CA19-9. Nilesson O,Johasson C,Gilmelius zzB,et al. British Journal of Cancer . 1992
[4]
Prognostic factor in colorectal cancer: college of American pathologists consensus statement 1999. Compton CC,Fielding LP,Burgart LJ,et al. Archives of Pathology and Laboratory Medicine . 2000
[5]
Comparison of a new tumor marker CA24 - 2 with CA19 - 9 and carcinoembryonic antigen(CEA) in digestive tract disease. Kuusela P,Haglund C,Robert PJ. British Journal of Cancer . 1991
[6]
Telomere length and telomerase activity in carcinogenesis of the stomach. Maruyama Y,Hanai H,Fujita M,et al. Japanese Journal of Clinical Oncology . 1997
[7]
Specific in serum of patients with colon carcinoma. Koprowski H,Herly M,Steplewski Z,et al. Science . 1981
[8]
Specific in serum of patients with colon carcinoma. Koprowski H,Herly M,Steplewski Z,et al. Science . 1981
[9]
Carcinoembryonic antigen screening: pros and cons. Macdonald JS. Seminars in Oncology . 1999
[10]
Comparison of serum CA72- 4 and CA19 - 9 levels in gastric patients and correlation with recurrence. Joypaul B,Broming M,Newman E,et al. The American Journal of Surgery . 1995